About: Correction of anemia with continuous erythropoietin receptor activator in Korean patients on long-term hemodialysis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Correction of anemia with continuous erythropoietin receptor activator in Korean patients on long-term hemodialysis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 26 December 2013

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2013 (ast) наукова стаття, опублікована в грудні 2013 (uk) مقالة علمية نشرت في 26 ديسمبر 2013 (ar) scientific article published on 26 December 2013 (en)
publication date	wds:Q37473690-9FACC06C-CEE9-45F6-9FD6-B8FF8419C961
publication date	2013-12-26 00:00:00Z (xsd:dateTime)
cites work	wds:Q37473690-01BF02C0-42BC-4AC9-B658-115286E92ABE wds:Q37473690-0BDE1CD0-60B5-4DBA-87A4-F4634294E4D9 wds:Q37473690-2ECB9B9B-747E-4FFB-AB5F-26048020B2B5 wds:Q37473690-4A763FBD-197F-49BF-89DD-45E349873D06 wds:Q37473690-5CD5266B-58C0-40E7-9CCC-1FDEB86221AD wds:Q37473690-6279950D-A85D-4CB3-A3E7-ACD706EE6C61 wds:Q37473690-6C2479DA-A102-4B6C-89AA-E8234E43A602 wds:Q37473690-6E0E8810-2E92-4A16-A8F1-253C475476AE wds:Q37473690-8B3D95EC-7741-427B-8843-C800F2B67D9C wds:Q37473690-97AFE6FC-3E5C-4C7C-A86F-6732E08CC35C wds:Q37473690-9A62D602-E8BF-4AE6-9777-9F8354B49D5F wds:Q37473690-9EFE33A8-E0DD-46E5-9AE6-DF41A715B871 wds:Q37473690-AF1B9CCC-179C-4022-BB1D-63A3B6E66EC4 wds:Q37473690-C0788A11-FEB6-4466-BE20-A475BFE0A06C wds:Q37473690-D76D8D71-82F1-46D1-9821-7D0801A451F4 wds:Q37473690-E29DB376-02EB-4B1B-86AF-21393FB7E762 wds:Q37473690-ED0B6B6B-2347-4DD1-9688-86C50ECFBFF2
cites work	C.E.R.A. corrects anemia in patients with chronic kidney disease not on dialysis: results of a randomized clinical trial. Intravenous C.E.R.A. maintains stable haemoglobin levels in patients on dialysis previously treated with darbepoetin alfa: results from STRIATA, a randomized phase III study. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure Pharmacokinetics and pharmacodynamics of intravenous and subcutaneous continuous erythropoietin receptor activator (C.E.R.A.) in patients with chronic kidney disease KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease Role of residual renal function in phosphate control and anemia management in chronic hemodialysis patients Residual renal function improves outcome in incremental haemodialysis despite reduced dialysis dose C.E.R.A. maintains stable control of hemoglobin in patients with chronic kidney disease on dialysis when administered once every two weeks. Epoetin alfa. Clinical evolution of a pleiotropic cytokine Pharmacokinetic and pharmacodynamic properties of methoxy polyethylene glycol-epoetin beta are unaffected by the site of subcutaneous administration C.E.R.A.: pharmacodynamics, pharmacokinetics and efficacy in patients with chronic kidney disease Intravenous methoxy polyethylene glycol-epoetin beta for haemoglobin control in patients with chronic kidney disease who are on dialysis: a randomised non-inferiority trial (MAXIMA). Once-Monthly Subcutaneous C.E.R.A. Maintains Stable Hemoglobin Control in Patients with Chronic Kidney Disease on Dialysis and Converted Directly from Epoetin One to Three Times Weekly Efficacy of Intravenous Methoxy Polyethylene Glycol-Epoetin Beta Administered Every 2 Weeks Compared With Epoetin Administered 3 Times Weekly in Patients Treated by Hemodialysis or Peritoneal Dialysis: A Randomized Trial Methoxy polyethylene glycol-epoetin beta: a review of its use in the management of anaemia associated with chronic kidney disease Monthly continuous erythropoietin receptor activator treatment maintains stable hemoglobin levels in routine clinical management of hemodialysis patients Evaluation of maintenance of stable haemoglobin levels in haemodialysis patients converting from epoetin or darbepoetin to monthly intravenous C.E.R.A.: the MIRACEL study
author name string	wds:Q37473690-21C65AEC-4275-420B-84B5-4EE15E5930FB wds:Q37473690-353EA2B3-6C6D-465A-8936-F000544F2C5E wds:Q37473690-47FFF22C-6E37-4993-9410-5CA64E3AFC95 wds:Q37473690-54901C3B-F223-4092-B128-15C4AB7000B4 wds:Q37473690-6C329131-6A86-478E-ACFE-DFC84D13C0AE wds:Q37473690-86A05D92-EBD5-4928-9113-921D6C55B3B7 wds:Q37473690-9E097268-FA67-485D-BD22-197A3631DB00 wds:Q37473690-AE701499-1C29-4205-9286-EE10A664FA4E wds:Q37473690-B0C6914C-BAD0-47CC-91E9-996F622B75B2 wds:Q37473690-D1F6A6DA-71C4-4E1B-BC64-13CCCC75EFCC wds:Q37473690-DFC62984-BCA1-48F7-9C3B-A177A510500D wds:Q37473690-FF53DE87-D951-4A23-93A3-5450F0FA5B49
author name string	Soo Jin Kim Bum Soon Choi Wookyung Chung Sejoong Kim Wooseong Huh Dong-Wan Chae Chul-Woo Yang Ha Young Oh Jieun Oh Kwon-Wook Joo Sung-Gyun Kim Ho-Jun Chin
rdfs:label	Correction of anemia with continuous erythropoietin receptor activator in Korean patients on long-term hemodialysis (en) Correction of anemia with continuous erythropoietin receptor activator in Korean patients on long-term hemodialysis (nl) Correction of anemia with continuous erythropoietin receptor activator in Korean patients on long-term hemodialysis (ast)
skos:prefLabel	Correction of anemia with continuous erythropoietin receptor activator in Korean patients on long-term hemodialysis (en) Correction of anemia with continuous erythropoietin receptor activator in Korean patients on long-term hemodialysis (nl) Correction of anemia with continuous erythropoietin receptor activator in Korean patients on long-term hemodialysis (ast)
name	Correction of anemia with continuous erythropoietin receptor activator in Korean patients on long-term hemodialysis (en) Correction of anemia with continuous erythropoietin receptor activator in Korean patients on long-term hemodialysis (nl) Correction of anemia with continuous erythropoietin receptor activator in Korean patients on long-term hemodialysis (ast)
author	wds:Q37473690-A332692B-A378-4DC9-B728-C2AA5DA56D78
author	Suhnggwon Kim
title	wds:Q37473690-229C96D2-D744-4D8D-94B8-B63214AFC5BA
title	Correction of anemia with continuous erythropoietin receptor activator in Korean patients on long-term hemodialysis (en)
page(s)	wds:Q37473690-F2BA9D13-CFAE-4F00-9FEC-AC528A8CB48F
page(s)	76-83
instance of	wds:Q37473690-4FDD069C-5EA5-4DD3-B7D1-EF0004F958ED
instance of	scholarly article
main subject	wds:Q37473690-F50009DF-D882-4605-A95D-907344092A43
main subject	wd:Q218706
PubMed ID	wds:Q37473690-0A41B538-A63C-4D85-BF02-5F0BC0BDB661
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24431909
PubMed ID	24431909
published in	wds:Q37473690-44CBF67F-6D80-4382-9D4F-634DB6690842

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software